About: Obesity as a contributor to immunopathology in pregnant and non‐pregnant adults with COVID‐19

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Obesity as a contributor to immunopathology in pregnant and non‐pregnant adults with COVID‐19 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Obesity as a contributor to immunopathology in pregnant and non‐pregnant adults with COVID‐19
Creator	Mccartney, Stephen Waldorf, Kristina Kachikis, Alisa Chandrasekaran, Suchi Huebner, Emily Walker, Christie
source	Medline; PMC
abstract	The ongoing coronavirus disease 2019 (COVID‐19) pandemic has led to a global public health emergency with the need to identify vulnerable populations who may benefit from increased screening and healthcare resources. Initial data suggests that overall, pregnancy is not a significant risk factor for severe coronavirus disease 2019 (COVID‐19). However, case series have suggested that maternal obesity is one of the most important co‐morbidities associated with more severe disease. In obese individuals, suppressors of cytokine signaling are upregulated and type I and III interferon responses are delayed and blunted leading to ineffective viral clearance. Obesity is also associated with changes in systemic immunity involving a wide range of immune cells and mechanisms that lead to low‐grade chronic inflammation, which can compromise antiviral immunity. Macrophage activation in adipose tissue can produce low levels of pro‐inflammatory cytokines (TNF‐α, IL‐1β, IL‐6). Further, adipocyte secretion of leptin is pro‐inflammatory and high circulating levels of leptin have been associated with mortality in patients with acute respiratory distress syndrome. The synergistic effects of obesity‐associated delays in immune control of COVID‐19 with mechanical stress of increased adipose tissue may contribute to a greater risk of pulmonary compromise in obese pregnant women. In this review, we bring together data regarding obesity as a key co‐morbidity for COVID‐19 in pregnancy with known changes in the antiviral immune response associated with obesity. We also describe how the global burden of obesity among reproductive age women has serious public health implications for COVID‐19.
has issue date	2020-08-11(xsd:dateTime)
bibo:doi	10.1111/aji.13320
bibo:pmid	32779790
has license	no-cc
sha1sum (hex)	c6ddfda76387c8adf1be3af836126a2785de59e5
schema:url	https://doi.org/10.1111/aji.13320
resource representing a document's title	Obesity as a contributor to immunopathology in pregnant and non‐pregnant adults with COVID‐19
has PubMed Central identifier	PMC7435524
has PubMed identifier	32779790
schema:publication	Am J Reprod Immunol
resource representing a document's body	covid:c6ddfda76387c8adf1be3af836126a2785de59e5#body_text
is schema:about of	named entity 'Word count' named entity 'obesity' named entity 'adjusted odds ratio' named entity 'IL-1' named entity 'COVID-19 in pregnancy' named entity 'innate immune' named entity 'immune cell' named entity 'global COVID-19 pandemic' named entity 'neutrophils' named entity 'obese' named entity 'obesity' named entity 'critically ill' named entity 'CD4+ T cell' named entity 'adipocyte' named entity 'pregnant women' named entity 'obese' named entity 'jejunum' named entity 'obese' named entity 'kidney' named entity 'inflammatory response' named entity 'cohort studies' named entity 'pregnant women' named entity 'hypertension' named entity 'obesity' named entity 'ICU' named entity 'obesity' named entity 'amnion' named entity 'mouse models' named entity 'adipocytes' named entity 'lung' named entity 'obesity' named entity 'Obese' named entity 'obese' named entity 'maladaptive' named entity 'kidney' named entity 'respiratory drive' named entity 'adipocytes' named entity 'pregnancy' named entity 'postpartum period' named entity 'pregnant women' named entity 'metabolic diseases' named entity 'pulmonary infection' named entity 'obese' named entity 'Th1' named entity 'diabetes' named entity 'overweight or obese' named entity 'endothelium' named entity 'pregnant women' named entity 'viral infections' named entity 'Obesity' named entity 'metabolic' named entity 'troponin' named entity 'chemokines' named entity 'pneumocytes' named entity 'reproductive age' named entity 'overweight or obese' named entity 'pro-inflammatory cytokines' named entity 'serine protease' named entity 'cytokines' named entity 'COVID-19 disease' named entity 'Adipose tissue' named entity 'carboxypeptidase' named entity 'high levels' named entity 'respiratory infections' named entity 'risk factor' named entity 'monocytes' named entity 'proinflammatory' named entity 'obesity paradox' named entity 'fatigue' named entity 'adaptive immunity' named entity 'obesity' named entity 'work of breathing' named entity 'COVID-19 disease' named entity 'BMI' named entity 'IL-6' named entity 'metabolic'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software